DXP604

· Wuhan Institute of Biological Products Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DXP604, covering 2022-05-19 to 2022-05-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19 [Phase 2]